SCHEMBL30392439

SCHEMBL30392439

COC(=O)c1ccc(-c2cccc(Nc3cc(N(C)Cc4ccc(OC)cc4)c4ncc(C(=O)N[C@@H]5C[C@@H]5F)n4n3)c2OC)nc1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.43
▸ PDE4D Q08499 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26103080 1.00 TYK2 (0.43) TYK2PDE4D
SCHEMBL30392771 0.95 TYK2 (0.43) TYK2PDE4D
SCHEMBL26098254 0.95 TYK2 (0.43) TYK2PDE4D
SCHEMBL26098984 0.90 TYK2 (0.41) TYK2PDE4D
SCHEMBL30392624 0.90 TYK2 (0.41) TYK2PDE4D
SCHEMBL30392726 0.89 TYK2 (0.40) TYK2PDE4D
SCHEMBL26102885 0.89 TYK2 (0.40) TYK2PDE4D
SCHEMBL26099068 0.89 TYK2 (0.44) TYK2PDE4D
SCHEMBL26101630 0.87 TYK2 (0.47) TYK2PDE4D
SCHEMBL26101378 0.86 TYK2 (0.61) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback